All News

Discussing the possibility of dying is an unfortunate reality for many patients with cancer and their loved ones, but it isn't a talk that should be avoided. In fact, it can lead to more healing and understanding.

Exploring your story can bring awareness and closure — and help you love this new version of yourself.

A roundup of the latest news and updates for patients with multiple myeloma from CURE®.

After losing the sister she raised to an aggressive type of liver cancer, one woman has devoted herself to stamping out the disease.

A cancer survivor reflects on how the COVID-19 pandemic can feel exhausting but notes that we can still persevere.

“These observations strongly suggest an underdiagnosis of COVID-19 in this population of cancer patients and a major underestimation of SARS-CoV-2 contribution as a cause of death in cancer patients,” the authors wrote. “The management of cancer patients with febrile respiratory symptoms in this period of the epidemic should, therefore, be particularly careful even in the absence of SARS-CoV-2 detection.”

A laryngectomy choir offers rehabilitation and inspiration to patients after throat cancer.

It's important to celebrate the mini-victories along the cancer journey, whether it's with your favorite food or a small parade.

Cancer changes everything about one’s self-image, but that doesn’t mean it is a negative outcome.

We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.

U.S. Supreme Court Justice Ruth Bader Ginsburg, 87, has announced that she is currently undergoing chemotherapy for a cancer recurrence.

According to the lead study investigator, work needs to be done to ensure financial toxicity is not a deterrent to clinical trial enrollment and that trial sponsors and payers should consider trial expense reimbursement.

It's easy to accept certain challenging side effects from the cancer journey as a "new normal", something you can't shake no matter what. But even with cancer fatigue feeling insurmountable, there are ways to handle it.

From U.S. Supreme Court Justice Ruth Bader Ginsburg being released from the hospital after an infection related to treatment for pancreatic tumor to Alex Trebek giving an update on the treatment of his stage 4 pancreatic cancer just days ahead of his 80th birthday, here’s what’s making the headlines in the cancer space this week.

In both diagnosis and treatment of cancer, there is a growing role for radiation drugs that are injected, ingested or inserted.

When it comes to hepatocellular carcinoma (HCC), doctors have a handful of treatment options at their disposal. But how do they decide what’s best?

A survivor of male breast cancer goes through what he wishes he knew before a breast cancer diagnosis.

CURE®’s summer recipe series continues with a simple three bean vegetable chili recipe that's loaded with protein and fiber.

The manufacturer is working with the Food and Drug Administration to address any requests including changes to the protocol of the MELANI-01 trial to enhance patient safety.

Channeling the fear of unwanted change into the hard-fought promise of a transformed life.

The Food and Drug Administration’s Oncologic Drugs Advisory Committee voted in favor of the agency approving belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma who have previously received at least four therapies.

The Food and Drug Administration in May approved 7 therapies to treat patients with non-small cell lung cancer. And although one expert notes that few are considered “practice changing”, patients should not be disheartened considering there have been so many advancements in the treatment of the disease.

The Multiple Myeloma Research Foundation’s newly launched CureCloud is a registry designed to collect clinical and genomic information about patients. Its goals are to help researchers discover treatments for various subtypes of the disease and let patients know whether they have any of 70 genetic aberrations associated with myeloma.

Dr. Pat Basu, president and CEO of Cancer Treatment Centers of America discusses the fear surrounding cancer screenings during the COVID-19 pandemic and finding the right balance between what is an essential visit and what can be done using telemedicine.

Plucking a fat and juicy blueberry from a new mastectomy bra reminded this breast cancer survivor that life can still be sweet.

Although the study failed to meet its goal of progression-free survival, overall survival data are currently not yet available, and follow-up will continue until the next planned analysis.

Most of the data from the recent approvals of several non-small cell lung cancer drugs don’t distinguish themselves regarding efficacy or safety to what was already available before the flurry of approvals in May, according to Dr. Timothy Burns.

Ten percent of women who received a hysterectomy and salpingectomy, or removal of the fallopian tubes, during the study period had a family history of breast or ovarian cancer.